Pharma Industry News

EMA validates Braftovi, Mektovi application for some mCRC

Currently, there are limited treatment options available that can prolong the lives of metastatic colorectal cancer patients.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]